Cannabis Bioscience International Holdings (CBIH) Liabilities and Shareholders Equity (2023 - 2026)

Cannabis Bioscience International Holdings has disclosed Liabilities and Shareholders Equity across 4 years of filings, most recently posting $1544.0 for Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $1544.0, down 89.63% year-over-year; the trailing twelve-month figure through Feb 2026 was $74497.0 (down 51.34% YoY), and the FY2025 annual result was $31880.0, down 44.23% from the prior year.
• Liabilities and Shareholders Equity came in at $1544.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $22131.0 in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $101842.0 in Q4 2023 to a low of $1544.0 in Q1 2026.
• The 4-year median for Liabilities and Shareholders Equity is $34766.0 (2024), against an average of $42435.4.
• Across the five-year window, Liabilities and Shareholders Equity soared 31.76% in 2024 and tumbled 89.63% in 2026, its largest moves.
• Cannabis Bioscience International Holdings' Liabilities and Shareholders Equity stood at $101842.0 in 2023, then tumbled by 65.86% to $34766.0 in 2024, then plunged by 36.34% to $22131.0 in 2025, then plunged by 93.02% to $1544.0 in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $1544.0 (Q1 2026), $22131.0 (Q4 2025), and $18942.0 (Q3 2025), per Business Quant data.